AERIS: A Breakthrough in Safer Sedation Airway Management

Transform Oral and Nasopharyngeal Airways into Advanced O2 Delivery & CO2 Monitoring Systems

The AERIS Airway™ seamlessly integrates and modernizes standard oropharyngeal (OPA) and nasopharyngeal (NPA) devices into dual-functioning systems by providing superior oxygen delivery while capturing reliable ETCO₂ data in real-time. The AERIS is a first-of-its-kind oxygen delivery and end-tidal CO2 monitoring device for safer I.V. sedation.

By offsetting the oxygen delivery port from the CO2 detection port, end tidal CO2 is captured at the supraglottis with minimal oxygen dilution, generating a real-time, reliable CO2 waveform on all clinical capnography monitors. Oxygen delivery is optimized using smooth laminar flow through the OPA or NPA channel.

Compatible with 95% of adult Guedel OPAs and NPAs, the AERIS can deliver FiO2 up to 80% using oxygen flow rates as low as 2-4 LPM and FiO2 up to 100% at flow rates of 6-10 LPM.

The AERIS Airway modernizes the practice of deep sedation, providing superior oxygen delivery and real-time CO2 monitoring, thereby limiting the risk of hypoxemia in patients and decreasing the amount of oxygen needed to maintain adequate oxygenation.

Benefits of the AERIS Airway

• Improved patient safety
• Enhanced workflow efficiency
• Lower morbidity
• Decreased oxygen use
• Decreased procedural costs